These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 22361403)

  • 1. Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy.
    Gerber BL; Rousseau MF; Ahn SA; le Polain de Waroux JB; Pouleur AC; Phlips T; Vancraeynest D; Pasquet A; Vanoverschelde JL
    J Am Coll Cardiol; 2012 Feb; 59(9):825-35. PubMed ID: 22361403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial positive pre-ejection velocity accurately detects presence of viable myocardium, predicts recovery of left ventricular function and bears a prognostic value after surgical revascularization.
    Penicka M; Tousek P; De Bruyne B; Wijns W; Lang O; Madaric J; Vanderheyden M; Tintera J; Malý M; Widimsky P; Bartunek J
    Eur Heart J; 2007 Jun; 28(11):1366-73. PubMed ID: 17208936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium.
    Mandegar MH; Yousefnia MA; Roshanali F; Rayatzadeh H; Alaeddini F
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):930-6. PubMed ID: 18954632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction.
    Williams MJ; Odabashian J; Lauer MS; Thomas JD; Marwick TH
    J Am Coll Cardiol; 1996 Jan; 27(1):132-9. PubMed ID: 8522686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.
    Kim RJ; Wu E; Rafael A; Chen EL; Parker MA; Simonetti O; Klocke FJ; Bonow RO; Judd RM
    N Engl J Med; 2000 Nov; 343(20):1445-53. PubMed ID: 11078769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral internal thoracic artery grafting improves long-term survival in patients with reduced ejection fraction: a propensity-matched study with 30-year follow-up.
    Galbut DL; Kurlansky PA; Traad EA; Dorman MJ; Zucker M; Ebra G
    J Thorac Cardiovasc Surg; 2012 Apr; 143(4):844-853.e4. PubMed ID: 22245240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of endocardial electromechanical mapping in patients with left ventricular dysfunction undergoing percutaneous coronary intervention.
    Koch KC; vom Dahl J; Schaefer WM; Nowak B; Kapan S; Hanrath P
    Am J Cardiol; 2004 Nov; 94(9):1129-33. PubMed ID: 15518606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction.
    Cheong BY; Muthupillai R; Wilson JM; Sung A; Huber S; Amin S; Elayda MA; Lee VV; Flamm SD
    Circulation; 2009 Nov; 120(21):2069-76. PubMed ID: 19901193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete percutaneous revascularization for multivessel disease in patients with impaired left ventricular function: pre- and post-procedural evaluation by cardiac magnetic resonance imaging.
    Kirschbaum SW; Springeling T; Boersma E; Moelker A; van der Giessen WJ; Serruys PW; de Feyter PJ; van Geuns RJ
    JACC Cardiovasc Interv; 2010 Apr; 3(4):392-400. PubMed ID: 20398866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of coronary surgery in mildly symptomatic patients with left ventricular dysfunction, multivessel disease and stenotic single residual patent vessel].
    Dalle Mule J; Zingone B; Bilardo G; Sponga B; Pellegrini P; Branchini B; Burelli C; Zanuttini D; Martinelli F; Perelli R
    G Ital Cardiol; 1995 May; 25(5):561-74. PubMed ID: 7642061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complexity of coronary artery disease affects outcome of patients undergoing coronary artery bypass grafting with impaired left ventricular function.
    Melina G; Angeloni E; Benedetto U; Monti F; Roscitano A; Serdoz R; Sinatra R
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):656-61. PubMed ID: 22995728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe left ventricular dyssynchrony is associated with poor prognosis in patients with moderate systolic heart failure undergoing coronary artery bypass grafting.
    Penicka M; Bartunek J; Lang O; Medilek K; Tousek P; Vanderheyden M; De Bruyne B; Maruskova M; Widimsky P
    J Am Coll Cardiol; 2007 Oct; 50(14):1315-23. PubMed ID: 17903629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of revascularization on long-term survival in patients with ischemic left ventricular dysfunction and a wide range of viability.
    Sawada SG; Dasgupta S; Nguyen J; Lane KA; Gradus-Pizlo I; Mahenthiran J; Feigenbaum H
    Am J Cardiol; 2010 Jul; 106(2):187-92. PubMed ID: 20599001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of myocardial contractile recovery after coronary revascularization in patients with prior myocardial infarction.
    Abdel-Salam Z; Nammas W
    Cardiovasc Revasc Med; 2010; 11(1):2-7. PubMed ID: 20129355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of myocardial revascularisation on left ventricular systolic function in patients with and without viable myocardium: should non-viable segments be revascularised?
    Stipac AV; Stankovic I; Vidakovic R; Putnikovic B; Ilic I; Milicic B; Neskovic AN
    Heart; 2013 Dec; 99(23):1749-54. PubMed ID: 23906733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study.
    Meluzín J; Cerný J; Frélich M; Stetka F; Spinarová L; Popelová J; Stípal R
    J Am Coll Cardiol; 1998 Oct; 32(4):912-20. PubMed ID: 9768711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advantages of myocardial revascularization after admission for critical limb ischemia in diabetic patients with coronary artery disease: data of a cohort of 564 consecutive patients.
    Faglia E; Clerici G; Caminiti M; Quarantiello A; Curci V; Morabito A
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1030-6. PubMed ID: 18799966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Prognostic Value of Late Gadolinium-Enhanced Magnetic Resonance Imaging in Patients With and Without Left Ventricular Dysfunction Undergoing Coronary Artery Bypass Grafting.
    Lee SA; Yoon YE; Kim JE; Park JJ; Oh IY; Yoon CH; Suh JW; Kim JS; Chun EJ; Cho YS; Youn TJ; Lim C; Cho GY; Chae IH; Park KH; Choi DJ; Choi SI
    Am J Cardiol; 2016 Dec; 118(11):1647-1654. PubMed ID: 27742424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy.
    Bello D; Shah DJ; Farah GM; Di Luzio S; Parker M; Johnson MR; Cotts WG; Klocke FJ; Bonow RO; Judd RM; Gheorghiade M; Kim RJ
    Circulation; 2003 Oct; 108(16):1945-53. PubMed ID: 14557364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.